Denali Therapeutics Income Statement (2017-2025) | DNLI

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.64M1.65M1.20M125.68M4.21M4.20M13.60M4.67M3.60M5.85M9.39M316.81M7.92M15.00M5.29M12.51M42.14M52.48M3.56M10.28M35.14M294.12M1.27M
Operating items
Research & Development 18.47M18.52M18.47M20.82M52.13M30.32M39.91M37.40M51.88M52.54M51.55M51.02M53.15M53.70M54.74M60.21M65.71M71.56M67.88M86.10M92.74M87.79M92.11M128.82M97.52M89.74M107.80M107.02M91.40M98.24M99.79M
Selling, General & Administrative 3.27M3.77M5.07M5.57M6.90M8.84M11.04M9.31M15.08M11.21M10.88M12.55M13.97M15.80M17.99M18.94M19.05M19.32M21.76M22.54M21.16M23.26M23.52M27.14M26.12M25.32M24.77M25.24M25.19M24.95M30.06M
Other Operating Expenses 14.54M
Operating Expenses 21.74M22.29M23.54M26.39M59.03M39.16M50.95M46.71M66.96M63.76M62.43M63.57M67.12M69.51M72.74M79.14M84.76M90.88M89.64M108.64M113.90M111.05M115.63M155.96M123.64M115.06M132.57M132.25M116.59M123.19M129.85M
Operating Income -21.74M-22.29M-23.54M-25.75M-57.38M-37.96M74.72M-42.51M-62.76M-50.16M-57.76M-59.97M-61.28M-60.12M244.08M-71.22M-61.82M-85.59M-77.12M-66.50M-61.42M-107.49M-105.34M-120.81M170.48M-113.80M-132.57M-117.72M-116.59M-123.19M-129.85M
EBIT -21.74M-22.29M-23.54M-25.75M-57.38M-37.96M74.72M-42.51M-62.76M-50.16M-57.76M-59.97M-61.28M-60.12M244.08M-71.22M-61.82M-85.59M-77.12M-66.50M-61.42M-107.49M-105.34M-120.81M170.48M-113.80M-132.57M-117.72M-116.59M-123.19M-129.85M
Non-operating items
Interest & Investment Income 11.03M12.90M14.44M13.13M15.91M17.57M15.99M15.16M
Non Operating Income 0.42M0.44M0.65M2.07M2.66M2.59M2.81M3.52M4.11M3.78M3.81M3.07M2.60M1.94M1.63M1.18M1.13M1.00M1.28M1.28M2.65M4.19M6.66M11.03M12.90M14.44M13.13M
Net income details
EBT -21.74M-22.29M-23.54M-25.75M-23.68M-35.37M77.53M-38.99M-58.65M-46.37M-53.95M-56.90M-58.68M-58.17M245.71M-70.04M-60.69M-84.59M-75.84M-66.50M-65.22M-103.30M-98.68M-109.78M-109.78M-99.35M-119.44M-101.80M-99.03M-107.19M-114.69M
Tax Provisions -0.31M-0.11M0.07M-0.14M0.08M0.06M0.82M-0.57M-0.01M0.03M
Profit After Tax -21.32M-21.84M-22.89M-23.68M-54.72M-35.37M77.53M-38.99M-58.34M-46.26M-54.02M-56.76M-58.76M-58.23M244.88M-70.04M-60.69M-84.59M-75.26M-65.22M-58.79M-103.30M-98.68M-109.78M183.38M-99.35M-119.47M-101.80M-99.03M-107.19M-114.75M
Income from Continuing Operations -21.74M-22.29M-23.54M-25.75M-23.68M-35.37M77.53M-38.99M-58.34M-46.26M-54.02M-56.76M-58.76M-58.23M244.88M-70.04M-60.69M-84.59M-75.26M-66.50M-65.22M-103.30M-98.68M-109.78M-109.78M-99.35M-119.47M-101.80M-99.03M-107.19M-114.69M
Consolidated Net Income -21.74M-22.29M-23.54M-25.75M-23.68M-35.37M77.53M-38.99M-58.34M-46.26M-54.02M-56.76M-58.76M-58.23M244.88M-70.04M-60.69M-84.59M-75.26M-66.50M-65.22M-103.30M-98.68M-109.78M-109.78M-99.35M-119.47M-101.80M-99.03M-107.19M-114.69M
Income towards Parent Company -21.74M-22.29M-23.54M-25.75M-23.68M-35.37M77.53M-38.99M-58.34M-46.26M-54.02M-56.76M-58.76M-58.23M244.88M-70.04M-60.69M-84.59M-75.26M-66.50M-65.22M-103.30M-98.68M-109.78M-109.78M-99.35M-119.47M-101.80M-99.03M-107.19M-114.69M
Net Income towards Common Stockholders -21.74M-22.29M-23.54M-25.75M-23.68M-35.37M77.53M-38.99M-58.34M-46.26M-54.02M-56.76M-58.76M-58.23M244.88M-70.04M-60.69M-84.59M-75.26M-66.50M-65.22M-103.30M-98.68M-109.78M-109.78M-99.35M-119.47M-101.80M-99.03M-107.19M-114.69M
Additional items
EPS (Basic) -2.36-2.14-0.74-0.26-0.59-0.380.82-0.41-0.61-0.48-0.56-0.55-0.56-0.542.30-0.58-0.50-0.69-0.62-0.53-0.48-0.84-0.75-0.801.34-0.72-0.87-0.68-0.59-0.63-0.68
EPS (Weighted Average and Diluted) 0.84-0.57-0.55-0.56-0.542.28-0.58-0.50-0.69-0.62-0.53-0.48-0.84-0.75-0.801.30-0.72-0.87-0.68-0.59-0.63-0.68
Shares Outstanding (Weighted Average) 87.98M87.98M94.43M94.44M94.81M94.96M95.29M95.48M95.84M96.03M96.03M105.63M105.98M119.92M120.98M120.98M121.19M121.64M122.13M122.83M122.95M123.35M136.68M136.68M136.89M137.42M138.20M139.16M142.61M143.17M145.22M145.28M146.21M146.21M
Shares Outstanding (Diluted Average) 92.62M95.61M102.42M105.72M107.49M112.70M120.88M121.29M121.74M121.52M122.67M123.01M123.47M125.53M136.52M140.93M137.64M137.37M149.40M168.83M169.46M164.47M171.22M171.45M172.42M
EBITDA -21.34M-21.70M-23.02M-24.60M-54.93M-35.29M78.30M-38.01M-57.79M-46.58M-54.24M-56.28M-59.04M-58.77M244.63M-70.03M-60.83M-84.74M-77.24M-71.97M-61.82M-102.88M-93.71M-105.41M184.46M-98.56M-118.18M-103.74M-100.39M-99.00M-118.26M
Tax Rate 0.530.240.240.330.760.01